Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1187, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Monoclonal anti-TNF antibodies may increase risk of herpes zoster
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
Access to resources
Recommend
Prednisone doses of < 7.5 mg/day are not associated with excess herpes zoster risk
Reactions Weekly, Vol. 1, Iss. 1281, 2009-01 ,pp. :
Early institution of DMARDs gives better outcome in RA
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
Etanercept considered cost effective vs DMARDs in RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. :
DMARDs dominate biological products for early RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 593, 2009-01 ,pp. :